Stay updated on Glycine Supplement for Severe COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Glycine Supplement for Severe COVID-19 Clinical Trial page.

Latest updates to the Glycine Supplement for Severe COVID-19 Clinical Trial page
- CheckyesterdayChange DetectedRevision updated to v3.5.2, replacing v3.5.0.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedThe page revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check37 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check65 days agoChange DetectedThis release adds Revision: v3.4.2 and removes an earlier funding notice, which are site-wide updates and do not modify the study page content or its data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check72 days agoChange DetectedAdded a government funding lapse notice with links to cc.nih.gov and updated the site revision to v3.4.1 (removing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check80 days agoChange DetectedAdded a 'Show glossary' toggle and updated capitalization for labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and the revision footer now shows 'Revision: v3.4.0' instead of 'v3.3.4'; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Glycine Supplement for Severe COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Glycine Supplement for Severe COVID-19 Clinical Trial page.